Doctor-Made stent could tame deadly aortic bulges
NCT ID NCT06501872
First seen Mar 27, 2026 · Last updated Jun 22, 2026 · Updated 12 times
Summary
This study tests a stent graft that doctors modify by hand to treat large bulges in the aorta (the body's main artery) that extend into the chest and belly. The goal is to see if this custom approach is safer and works as well as traditional open surgery. About 80 people aged 50 and older with aneurysms meeting standard size criteria will receive the modified stent. Researchers will track survival, major complications, and success of the procedure over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC ANEURYSM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dartmouth-Hitchcock Medical Center
RECRUITINGLebanon, New Hampshire, 03756, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Physician-modified aortic endograft (a stent graft customized by the doctor)
What this could lead to
If successful, this could offer a less invasive treatment option for complex aortic aneurysms, potentially reducing recovery time and complications compared to open surgery.
What could go wrong
This is an early-stage study with only 80 participants, so results may not apply to everyone. Risks include serious complications like organ failure, stroke, or need for additional procedures.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.